Show
Sort by
-
- Journal Article
- A1
- open access
On-target pharmacodynamic activity of the PI3K inhibitor copanlisib in paired biopsies from patients with malignant lymphoma and advanced solid tumors
-
Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of non-Hodgkin lymphoma
-
Functional analysis of the p53 pathway in neuroblastoma cells using the small-molecule MDM2 antagonist Nutlin-3
-
The quassinoid derivative NBT-272 targets both the AKT and ERK signaling pathways in embryonal tumors
-
Monoclonal antibody 14C5 targets integrin alpha(v)beta(3)
-
Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFN gamma-based cancer therapy in mice
-
Topoisomerase-II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel